Common injection sites include the abdomen (at least two inches from the navel), the front of the thighs, and the upper arm
No, seizures are not listed as a known adverse effect in FDA prescribing information for semaglutide (Wegovy, Ozempic) or other GLP-1 receptor agonists
The active ingredient, Semaglutide GLP-1, mimics a hormone that helps control insulin production and slow stomach emptying, promoting a feeling of fullness and reducing the urge to overeat
Semaglutide generally produces greater average weight loss, but Liraglutide is also effective for steady results
Your doctor or pharmacist can tell you more about these interactions and any others that may occur with use of Rybelsus
Combining best-in-class digital tools with a frictionless pharmacy experience represents the future of patient-centric healthcare. The label on each FDA-approved GLP-1 medication makes clear they are to be used as an adjunct to a reduced-calorie diet and increased physical activity